Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-338435
Filing Date
2021-11-23
Accepted
2021-11-23 16:02:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d261318ddefa14a.htm DEFA14A 44471
2 GRAPHIC g261318g1123024802493.jpg GRAPHIC 2863
  Complete submission text file 0001193125-21-338435.txt   49661
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-50484 | Film No.: 211438498
SIC: 2834 Pharmaceutical Preparations